| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.05 | 0.8 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |